ダウンロード数: 154
このアイテムのファイル:
ファイル | 記述 | サイズ | フォーマット | |
---|---|---|---|---|
32_1161.pdf | 245.16 kB | Adobe PDF | 見る/開く |
タイトル: | 淋菌性尿道炎に対するNorfloxacinの臨床効果 |
その他のタイトル: | Clinical evaluation of norfloxacin in gonococcal urethritis |
著者: | 三木, 正也 神保, 進 真下, 透 山中, 英寿 |
著者名の別形: | MIKI, Masaya JINBO, Susumu MASHIMO, Tohru YAMANAKA, Hidetoshi |
キーワード: | Gonococcal urethritis Norfloxacin |
発行日: | Aug-1986 |
出版者: | 泌尿器科紀要刊行会 |
誌名: | 泌尿器科紀要 |
巻: | 32 |
号: | 8 |
開始ページ: | 1161 |
終了ページ: | 1165 |
抄録: | Norfloxacin, a new quinolinecarboxylic acid derivative, was administered to 30 male patients with gonococcal urethritis at a daily dose of 600 mg for 7-21 days. The clinical response was evaluated after administration of 7 days as excellent; Negative culture of N. gonorrhoeae. WBC less than 3/hpf in first voided urine sediment, good; Negative culture, WBC greater than or equal to 3/hpf, and poor; Positive culture. The result was excellent in 14 cases and good in 16 cases. No subjective side effects were observed. The minimum inhibitory concentration (MIC) distribution against the clinically isolated 30 strains of N. gonorrhoeae ranged from 0.0096 micrograms/ml to 0.34 micrograms/ml. Seven of thirty strains were resistant to ABPC. The MIC of these 7 strains ranged from 0.018 micrograms/ml to 0.18 micrograms/ml. Seven cases with ABPC resistant strains had a similar clinical response to other cases. Twelve patients (40%) developed post gonococcal urethritis for 7-14 days after treatment. Clinical observation of this series suggests that a 7 day therapy of Norfloxacin for the patients with gonococcal urethritis is sufficiently effective and that treatment should be changed to other antibacterial agents in the case of post gonococcal urethritis, since continuous administration for more than 7 days of Norfloxacin is not so effective. |
URI: | http://hdl.handle.net/2433/118882 |
PubMed ID: | 3788742 |
出現コレクション: | Vol.32 No.8 |
このリポジトリに保管されているアイテムはすべて著作権により保護されています。